Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,726 | -42,967 | -60,098 | -55,609 | -38,370 |
| Depreciation Amortization | 1,754 | 1,638 | 1,580 | 1,846 | 2,004 |
| Accounts receivable | -2,240 | -872 | -106 | 73 | -58 |
| Accounts payable and accrued liabilities | 2,120 | 9,389 | 3,061 | -333 | -1,137 |
| Other Working Capital | 15,456 | 10,736 | 2,422 | 13,653 | 6,581 |
| Other Operating Activity | 35,480 | 8,574 | 14,049 | 5,028 | -476 |
| Operating Cash Flow | $-21,156 | $-13,503 | $-39,093 | $-35,342 | $-31,457 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -116 | -13 | 242 | -11 | -5 |
| PPE Investments | -916 | -355 | -97 | -270 | -110 |
| Purchase Sale Intangibles | -2 | -10 | -1 | -6 | -13 |
| Other Investing Activity | -2 | -10 | 0 | -6 | -14 |
| Investing Cash Flow | $-1,033 | $-378 | $145 | $-286 | $-128 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 162 | N/A | N/A | 11,823 |
| Debt Repayment | -3,328 | -3,216 | -3,837 | -3,352 | -286 |
| Common Stock Issued | N/A | 65,105 | N/A | 51 | 129,828 |
| Other Financing Activity | -2,229 | -11,431 | -2,117 | -2,828 | -13,692 |
| Financing Cash Flow | $-5,557 | $50,620 | $-5,954 | $-6,129 | $127,674 |
| Exchange Rate Effect | 102 | -55 | 87 | 76 | -72 |
| Beginning Cash Position | 81,464 | 44,794 | 88,419 | 140,968 | 40,088 |
| End Cash Position | 53,820 | 81,479 | 43,606 | 99,287 | 136,106 |
| Net Cash Flow | $-27,643 | $36,685 | $-44,813 | $-41,681 | $96,017 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,156 | -13,503 | -39,093 | -35,342 | -31,457 |
| Capital Expenditure | -916 | -355 | -97 | -270 | -110 |
| Free Cash Flow | -22,072 | -13,858 | -39,190 | -35,611 | -31,566 |